The international workshop on CLL updated the prognostic criteria for their consensus guideline to include all of the following EXCEPT mutational status in which gene? READ MORE
Some oncologists may be more likely to prescribe certain cancer medicines when they receive payments from the companies that make these drugs.
Treatment with a BTK inhibitor has been shown to yield good depth and duration of response in patients with chronic lymphocytic leukemia, regardless of TP53 status.
Research presented at the 2018 BMT Tandem Meetings showed that potential role of immune checkpoint inhibitors in the post-transplant setting for patients with relapsed or large B-cell lymphomas.
A study to be presented at the BMT Tandem Meetings found no difference in OS for patients aged 55-64 years compared with those aged 65 years and older with non-Hodgkin lymphoma who underwent alloHCT.
The international workshop on CLL updated the prognostic criteria for their consensus guideline to include all of the following EXCEPT mutational status in which gene?
The National Comprehensive Cancer Network updated their induction and consolidation treatment recommendations for low-risk and high-risk acute myeloid leukemia.
From December 9-12, 2017, the American Society of Hematology hosted its Annual Meeting and Exposition in Atlanta, Georgia. The meeting provided an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology as well as to network with top minds in the field.